Italia markets closed

FTSE MIB
34.249,77
+310,02(+0,91%)
Dow Jones
38.239,66
+153,86(+0,40%)
Nasdaq
15.927,90
+316,14(+2,03%)
Nikkei 225
37.934,76
+306,28(+0,81%)
Petrolio
83,66
+0,09(+0,11%)
Bitcoin EUR
58.852,94
-1.509,96(-2,50%)

Alcon Inc. (ALC)

NYSE - NYSE Prezzo differito. Valuta in USD.

Aggiungi a watchlist

78,77

-0,07

(-0,09%)

Alla chiusura: 04:00PM EDT

78,01

-0,76

(-0,96%)

Dopo ore:

04:06PM EDT

I prezzi di scambio non provengono da tutti i mercati

Capitalizzazione	38,913B
Beta (5 anni mensile)	0,67
Rapporto PE (ttm)	40,19
EPS (ttm)	1,96
Prossima data utili	N/D
Rendimento e dividendo (futuro)	0,27 (0,35%)
Data ex dividendo	10 mag 2024
Stima target 1A	91,68

Tutte

GlobeNewswire
Lifecore Biomedical Enters into $150.0 Million in New Financing, Repays its Outstanding Term Loans and Signs New Supply Agreement to Expand HA Fermentation Capacity with Existing Long-Term Customer
New $150 million credit arrangements include six-year credit agreement and equipment sale and leaseback to replace existing term loanCHASKA, Minn., May 22, 2023 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (“Lifecore” or the “Company” Nasdaq: LFCR), a fully integrated contract development and manufacturing organization (“CDMO”), today announced that it has entered into a broad set of agreements with its long-term customer, Alcon (SIX/NYSE: ALC), which provides for the repayment of the Company’s